Full Text
PCN32 Cost Savings With Bevacizumab Compared to Sunitinib in the Treatment of MRCC

Abstract

Authors

V. Benkovic D. Jelec S. Antolic R. Stevanovic

Back to Volume 14, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×